Indianapolis, IN, United States of America

Martha A Kral



Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2004-2007

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Martha A. Kral in Pharmaceutical Development

Introduction: Martha A. Kral is a notable inventor based in Indianapolis, IN, whose groundbreaking work has led to significant advancements in the field of pharmaceuticals. With a total of two patents under her name, she has made strides in developing compositions aimed at addressing crucial health issues, particularly in the realm of sexual dysfunction.

Latest Patents: Kral's latest inventions include a patent for β-carboline pharmaceutical compositions, which encompass formulations containing a PDE5 inhibitor combined with a water-soluble diluent, a lubricant, a hydrophilic binder, a disintegrant, and optional microcrystalline cellulose and/or a wetting agent. This innovative product is designed to assist in treating sexual dysfunction. Another notable patent is for β-carboline drug products, which details a compound of a specific structural formula along with pharmaceutically acceptable salts and solvates, ensuring the compound is presented in a free drug particulate form.

Career Highlights: Martha Kral has been an integral part of Lilly Icos LLC, a company recognized for its dedication to innovative pharmaceutical solutions. Her work there showcases her commitment to enhancing medical treatments and improving patient outcomes through her inventive approaches.

Collaborations: Throughout her career, Kral has collaborated with esteemed colleagues, including Neil R. Anderson and Peter L. Oren. These partnerships reflect her collaborative spirit and dedication to advancing the field through teamwork and shared expertise.

Conclusion: Martha A. Kral exemplifies the impact that a dedicated inventor can have on the pharmaceutical industry. Her patents not only represent her personal achievements but also contribute significantly to innovations that can improve the quality of life for many individuals. As she continues her work at Lilly Icos LLC, her future contributions are highly anticipated within the realm of pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…